Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis

被引:23
作者
Dubin, Ruth [1 ]
Shlipak, Michael [1 ,2 ]
Li, Yongmei
Ix, Joachim [3 ]
de Boer, Ian H. [4 ]
Jenny, Nancy [5 ]
Peralta, Carmen A. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA
[2] San Francisco VA Med Ctr, Div Gen Internal Med, San Francisco, CA USA
[3] Univ Calif San Diego, San Diego Vet Affairs Healthcare Syst, La Jolla, CA 92093 USA
[4] Univ Washington, Dept Nephrol, Seattle, WA 98195 USA
[5] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA
关键词
C-reactive protein; estimated glomerular filtration rate by cystatin; pentraxin-3; race/ethnicity; serum amyloid protein; SERUM CYSTATIN-C; CARDIOVASCULAR-DISEASE; RENAL-FUNCTION; UNITED-STATES; PTX3; HEART; RISK; HYPERTENSION; INFLAMMATION; PREVALENCE;
D O I
10.1093/ndt/gfq648
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Pentraxin-3 (PTX3), an inflammatory marker thought to be related to vascular inflammation, is elevated in advanced chronic kidney disease (CKD). Whether PTX3 is associated with mild to moderate kidney dysfunction is unknown. Methods. We tested associations of proteins in the pentraxin family [PTX3, C-reactive protein (CRP) and serum amyloid protein (SAP)] with estimated glomerular filtration rate by cystatin C (eGFRcys) and microalbuminuria among 2824 participants in the Multi-Ethnic Study of Atherosclerosis. Associations were tested using multivariable linear regression with adjustment for demographics (age, gender, annual income), comorbidities (diabetes, hypertension, smoking, body mass index, low-density lipoprotein, high-density lipoprotein, triglycerides, ACE inhibitor and statin use) and systemic inflammation [interleukin-6 (IL-6)]. Results. Among the 2824 participants, mean age was 62 years and mean eGFRcys was 94 mL/min/1.73 m(2); 25% were white, 25% Chinese, 25% African-American and 25% Hispanic. Among all participants after full adjustment, higher PTX3 was associated with lower eGFRcys independently of IL-6 (beta-3.0 mL/min/1.73 m(2) per unit increase in lnPTX3, P < 0.001). In contrast, CRP and SAP were associated with eGFRcys in demographic adjusted models, but these associations were attenuated after adjustment for comorbidities and IL-6 (lnCRP beta-0.06, P = 0.9; lnSAP beta-0.35, P = 0.7). There was a significant interaction with race/ethnicity (P < 0.001) in the association of PTX3 and eGFRcys. After adjustment for demographics, comorbidities and IL-6, this association was significant in blacks (beta-5.7 mL/min/1.73 m(2) per unit increase in lnPTX3, P = 0.002) but not in Hispanics (beta-2.4, P = 0.1), Chinese (beta-0.91, P = 0.5) or whites (beta-0.26, P = 0.9). PTX3 and CRP, but not SAP, had correlations with microalbuminuria in unadjusted models (Spearman coefficients PTX3 0.05, P = 0.005; CRP 0.07, P < 0.001; SAP 0.013, P = 0.5), but these were attenuated after full adjustment. Conclusions. Endovascular inflammation may be an important mechanism associated with early kidney dysfunction, particularly among blacks. This mechanism appears to be independent of IL-6-regulated pathways.
引用
收藏
页码:1903 / 1908
页数:6
相关论文
共 30 条
[1]  
[Anonymous], USRDS 2004 ANN DAT R
[2]   Distribution and correlates of arterial compliance measures in asymptomatic young adults: The Bogalusa Heart Study [J].
Bhuiyan, AR ;
Li, SX ;
Li, H ;
Chen, W ;
Srinivasan, SR ;
Berenson, GS .
AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) :684-691
[3]   Multi-ethnic study of atherosclerosis: Objectives and design [J].
Bild, DE ;
Bluemke, DA ;
Burke, GL ;
Detrano, R ;
Roux, AVD ;
Folsom, AR ;
Greenland, P ;
Jacobs, DR ;
Kronmal, R ;
Liu, K ;
Nelson, JC ;
O'Leary, D ;
Saad, MF ;
Shea, S ;
Szklo, M ;
Tracy, RP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (09) :871-881
[4]   An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm [J].
Bottazzi, Barbara ;
Doni, Andrea ;
Garlanda, Cecilia ;
Mantovani, Alberto .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28, 2010, 28 :157-183
[5]   Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease [J].
Briet, M ;
Bozec, E ;
Laurent, S ;
Fassot, C ;
London, GM ;
Jacquot, C ;
Froissart, M ;
Houillier, P ;
Boutouyrie, P .
KIDNEY INTERNATIONAL, 2006, 69 (02) :350-357
[6]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[7]   Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988-1994 and 1999-2004 [J].
Cutler, Jeffrey A. ;
Sorlie, Paul D. ;
Wolz, Michael ;
Thom, Thomas ;
Fields, Larry E. ;
Roccella, Edward J. .
HYPERTENSION, 2008, 52 (05) :818-827
[8]  
Duprez DA, 2009, ETHNIC DIS, V19, P243
[9]  
*FDN NK, 2002, NKF KDOQI CLIN PRACT
[10]   Relations of Measures of Endothelial Function and Kidney Disease: The Framingham Heart Study [J].
Foster, Meredith C. ;
Keyes, Michelle J. ;
Larson, Martin G. ;
Vita, Joseph A. ;
Mitchell, Gary F. ;
Meigs, James B. ;
Vasan, Ramachandran S. ;
Benjamin, Emelia J. ;
Fox, Caroline S. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (05) :859-867